Yuexiu-Backed Biotech Firm Yikon Gets $31M Funding From KingMed Diagnostics-Linked Fund

Yikon Genomics, a reproductive health-focused biotech firm, announces on Monday that it has completed RMB220 million (US$31.3 million) in a series C funding round led by venture capital firm Jinhe Capital under independent clinical laboratory KingMed Diagnostics.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets